Skip to content
- 2022 – now: Head of Cancer Cell Signaling, Boehringer Ingelheim RCV, Vienna, Austria. Researching new therapeutic approaches for the treatment of cancer.
- 2020 – 2022: Scientific Director, Boehringer Ingelheim RCV, Vienna, Austria.
- 2015 – 2020: Principal Scientist (Research Laboratory Head), Boehringer Ingelheim RCV, Vienna, Austria.
- 2014 – 2015: Group Leader, Gene Center LMU Munich, Germany & Independent Research Fellow, IMBA-Institute of Molecular Biotechnology, Vienna, Austria.
- 2013 – 2014: Research Laboratory Head, Boehringer Ingelheim RCV, Vienna, Austria.
- 2010 – 2013: Postdoctoral Fellow, Harvard Medical School, Laboratory of Professor Norbert Perrimon, Boston, USA.
- 2009 – 2010 : Postdoctoral Fellow, IMBA-Institute of Molecular Biotechnology, Laboratory of Professor Jürgen Knoblich, Vienna, Austria.
- 2005 – 2009: Ph.D., Vienna Biocenter International Ph.D. program, Laboratory of Dr. Jürgen Knoblich at the IMBA-Institute of Molecular Biotechnology Austria.
- 2003 – 2005: Master degree in Biology (Human Biology, Genetics), Brain Research Institute, Laboratory Dr. Ruth Herbst.
- 1999 – 2005: Undergraduate Studies, Biology (Human Biology, focus on Human Genetics and Neurobiology) at the Faculty of Natural Sciences, University of Vienna.
WordPress Cookie Plugin by Real Cookie Banner
